The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Oh wow, thatâs brand new information.
You have definitely never mentioned that before!
No one has said it isnât top priority Dan, it certainly gets top billing within the RNS.
Are you doing this deliberately? So because there was no major announcement about CS then it means itâs been abandoned?
Even though the RNS talks about the project and specifically says itâs the main focus?
So he hasnât moved on and he hasnât really said anything that makes people think he has?
Yet we are all having a discussion about PC abandoning the CS project and moving on?
Come on guys.
Sorry again, what have I missed? Why on earth do people think he has moved on?
What makes you all say that? Have I missed a bit?
What makes you think Patrick is about to jump projects again?
Do you mean your posting history safe?
If so, I would agree.
You keep telling us nobody will give them money, now the money they raise wonât last. Your goalposts keep moving.
An explorer will have that record, until they donât, thatâs the point.
Thatâs what investing in an explorer is all about Sheldrake. They often donât have any revenues at all until, all of a sudden they do.
If you were surprised by that then it really wasnât the investment for you.
I donât buy this idea of âPozz not gone anywhereâ. These things take time, there is a permit and then deals need to be discussed. Sometimes that could be years to sort that out but in this case we have a crazy world at the moment where money has become tight and priorities are constantly changing.
This could take another year for all we know, that doesnât mean anything bad necessarily. The company has certainly moved forward in the last few years, saying otherwise is daft.
Dan1nat1 you said yesterday âMaybe in the same place as 2 years ago? Or would you say slightly worse, now the âflagshipâ doesnât even get a mention in the latest keep the lights on raise.â
The flagship projects get mentioned in the first sentence of the RNS?
I donât think we will see that here though? The company chooses whether any more investment goes in and the option for them to do that has been pegged at 5 months from now.
Maybe these guys bring more than just money?
If Tolsa has stated that they were not going to proceed then that would have needed an RNS.
Sres is absolutely not in the same place as it was 5 years ago.
Some play the long game though âŚ.
Why donât we all drop him a line and ask him for one? He has always been very good at responding, even if he does so from a position of CEO and is mindful of what he says.
All we can really do is show him what the sentiment is.
Not sure, Dan1nat1 I think and probably Sheldrake for all we know.
A very small part of it is a discounted placing to be fair, the massive bulk of it is not.